PLEASANTON, CA--(Marketwire - April 18, 2008) - Lipid Sciences, Inc. (NASDAQ: LIPD) presented new anti-inflammatory data supporting the Company’s HDL Mimetic Peptide development program at the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Annual Conference 2008 in Atlanta, Georgia. The presentation entitled, “An ApoA-I Mimetic Peptide LSI-518P Exhibits ABCA1 Specific Efflux and Anti-Inflammatory Properties” was made on April 17, 2008 by Dr. H. Bryan Brewer, Jr., Chief Scientific Director of Lipid Sciences.
